Literature DB >> 27665203

Depressive Symptoms, Cardiac Disease Severity, and Functional Status in Patients With Coronary Artery Disease (from the Heart and Soul Study).

David W Schopfer1, Mathilda Regan2, Paul A Heidenreich3, Mary A Whooley4.   

Abstract

Patient-reported health status is highly valued as a key measure of health care quality, yet little is known about the extent to which it is determined by subjective perception compared with objective measures of disease severity. We sought to compare the associations of depressive symptoms and objective measures of cardiac disease severity with perceived functional status in patients with stable coronary artery disease. We assessed depressive symptoms, severity of cardiovascular disease, and perceived functional status in a cross-sectional study of 1,023 patients with stable coronary artery disease. We compared the extent to which patient-reported functional status was influenced by depressive symptoms versus objective measures of disease severity. We then evaluated perceived functional status as a predictor of subsequent cardiovascular hospitalizations during 8.8 years of follow-up. Patients with depressive symptoms were more likely to report poor functional status than those without depressive symptoms (44% vs 17%; p <0.001). After adjustment for traditional risk factors and co-morbid conditions, independent predictors of poor functional status were depressive symptoms (odds ratio [OR] 2.68, 95% confidence interval [CI] 1.89 to 3.79), poor exercise capacity (OR 2.30, 95% CI 1.65 to 3.19), and history of heart failure (OR 1.61, 95% CI 1.12 to 2.29). Compared with patients who had class I functional status, those with class II functional status had a 96% greater rate (hazard ratio 1.96, 95% CI 1.15 to 3.34) and those with class III or IV functional status had a 104% greater rate (hazard ratio 2.04, 95% CI 1.12 to 3.73) of hospitalization for HF, adjusted for baseline demographic characteristics, co-morbidities, cardiac disease severity, and depressive symptoms. In conclusion, depressive symptoms and cardiac disease severity were independently associated with patient-reported functional status. This suggests that perceived functional status may be as strongly influenced by depressive symptoms as it is by cardiovascular disease severity. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27665203     DOI: 10.1016/j.amjcard.2016.07.062

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Effects of Gender-Specific Differences, Inflammatory Response, and Genetic Variation on the Associations Among Depressive Symptoms and the Risk of Major Adverse Coronary Events in Patients With Acute Coronary Syndrome.

Authors:  Jennifer Sanner; Megan L Grove; Erica Yu; F Gerard Moeller; Stanley G Cron; Eric Boerwinkle; Alanna C Morrison; Lorraine Frazier
Journal:  Biol Res Nurs       Date:  2018-01-03       Impact factor: 2.522

2.  Assessing the severity of cardiovascular disease in 213 088 patients with coronary heart disease: a retrospective cohort study.

Authors:  Salwa S Zghebi; Mamas A Mamas; Darren M Ashcroft; Martin K Rutter; Harm VanMarwijk; Chris Salisbury; Christian D Mallen; Caroline A Chew-Graham; Nadeem Qureshi; Stephen F Weng; Tim Holt; Iain Buchan; Niels Peek; Sally Giles; David Reeves; Evangelos Kontopantelis
Journal:  Open Heart       Date:  2021-04

3.  Retrospective analysis of exercise capacity in patients with coronary artery disease after percutaneous coronary intervention or coronary artery bypass graft.

Authors:  Ying Li; Xue Feng; Biyun Chen; Huaping Liu
Journal:  Int J Nurs Sci       Date:  2021-06-03

4.  Prevalence and determinants of depressive symptoms in patients with Chagas cardiomyopathy and predominantly preserved cardiac function.

Authors:  Whesley Tanor Silva; Matheus Ribeiro Ávila; Lucas Frois Fernandes de Oliveira; Pedro Henrique Scheidt Figueiredo; Vanessa Pereira Lima; Alessandra de Carvalho Bastone; Fábio Silva Martins da Costa; Mauro Felippe Felix Mediano; Henrique Silveira Costa; Manoel Otávio da Costa Rocha
Journal:  Rev Soc Bras Med Trop       Date:  2020-11-06       Impact factor: 1.581

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.